Coronary Artery Disease: A Key Issue in Type 2 Myocardial Infarction: Systematic Review and Recent Findings

Yao, Hermann; Zeller, Marianne; N’Guetta, Roland; Cottin, Yves; Putot, Alain

doi:10.3390/jcm12196412

Open AccessReview

Coronary Artery Disease: A Key Issue in Type 2 Myocardial Infarction: Systematic Review and Recent Findings

by

Hermann Yao

^1,2,*

,

Marianne Zeller

¹

,

Roland N’Guetta

²,

Yves Cottin

³

and

Alain Putot

⁴

¹

PEC2, EA 7460, UFR Health Sciences, University of Bourgogne Franche Comté, 25000 Dijon, France

²

Interventional Cardiology Department, Abidjan Heart Institute, Abidjan 01 BP V 206, Côte d’Ivoire

³

Cardiology Department, University Hospital Center Dijon Bourgogne, 21000 Dijon, France

⁴

Internal Medicine Department, Mont Blanc Hospital, 74703 Sallanches, France

^*

Author to whom correspondence should be addressed.

J. Clin. Med. 2023, 12(19), 6412; https://doi.org/10.3390/jcm12196412

Submission received: 27 August 2023 / Revised: 27 September 2023 / Accepted: 6 October 2023 / Published: 9 October 2023

(This article belongs to the Section Cardiology)

Download

Browse Figures

Versions Notes

Abstract

Underlying coronary artery disease (CAD) is increasingly considered to be a key issue in the pathophysiology of type 2 myocardial infarction (T2MI). In T2MI, which is attributable to a mismatch between oxygen supply/demand, CAD is common and appears to be more severe than in type 1 myocardial infarction (T1MI). Little is known about the heterogeneous mechanisms that cause supply/demand imbalance and non-coronary triggers leading to myocardial ischemia or about how they are potentially modulated by the presence and severity of CAD. CAD seems to be underrecognized and undertreated in T2MI, even though previous studies have demonstrated both the short and long-term prognostic value of CAD in T2MI. In this literature review, we attempt to address the prevalence and severity of CAD, challenges in the discrimination between T2MI and T1MI in the presence of CAD, and the prognostic value of CAD among patients with T2MI.

Keywords: type 2 myocardial infarction; coronary angiography; coronary artery disease; prognosis; secondary prevention medications

Share and Cite

MDPI and ACS Style

Yao, H.; Zeller, M.; N’Guetta, R.; Cottin, Y.; Putot, A. Coronary Artery Disease: A Key Issue in Type 2 Myocardial Infarction: Systematic Review and Recent Findings. J. Clin. Med. 2023, 12, 6412. https://doi.org/10.3390/jcm12196412

AMA Style

Yao H, Zeller M, N’Guetta R, Cottin Y, Putot A. Coronary Artery Disease: A Key Issue in Type 2 Myocardial Infarction: Systematic Review and Recent Findings. Journal of Clinical Medicine. 2023; 12(19):6412. https://doi.org/10.3390/jcm12196412

Chicago/Turabian Style

Yao, Hermann, Marianne Zeller, Roland N’Guetta, Yves Cottin, and Alain Putot. 2023. "Coronary Artery Disease: A Key Issue in Type 2 Myocardial Infarction: Systematic Review and Recent Findings" Journal of Clinical Medicine 12, no. 19: 6412. https://doi.org/10.3390/jcm12196412

APA Style

Yao, H., Zeller, M., N’Guetta, R., Cottin, Y., & Putot, A. (2023). Coronary Artery Disease: A Key Issue in Type 2 Myocardial Infarction: Systematic Review and Recent Findings. Journal of Clinical Medicine, 12(19), 6412. https://doi.org/10.3390/jcm12196412

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Coronary Artery Disease: A Key Issue in Type 2 Myocardial Infarction: Systematic Review and Recent Findings

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI